This study examined the prevalence of acute stress reactions to recent life events among persons living with HIV/AIDS. A second aim was to investigate the relationship of acute stress reactions among HIV-infected men and women to posttraumatic stress disorder (PTSD) symptoms to previous traumatic life events.
Method:
Participants included 64 HIV-seropositive persons (33 men and 31 women) drawn from a larger study examining the effects of group therapy on quality of life and health behavior. These individuals were assessed at baseline on demographic and medical status characteristics and (PTSD) symptoms and then randomly assigned to either receive group therapy plus education or education alone. Three months later they were assessed for acute stress reactions to recent life events.
Results:
Nearly a third (31.3 percent) of the participants reported levels of acute stress reactions to recent life events that met all symptom criteria for the diagnosis of acute stress disorder. However, only 9.4 percent of the respondents described a recent stressful life event that was threatening to the life or physical integrity of themselves or others. Acute stress reactions to recent life events were significantly and positively related to experiencing PTSD symptoms to prior traumatic life events. Acute stress did not differ significantly by gender, AIDS status, or whether or not participants had received 12 weeks of group therapy.
Conclusions:
A subset of individuals with HIV/AIDS experience high levels of acute stress reactivity to life events considered non-traumatic. HIV-infected individuals who react strongly to ongoing life stressors are more likely to have developed PTSD symptoms in response to previous traumatic life events.
Centers for Disease Control and Prevention. The global/HIV/AIDS Epidemic, 2001. Morbidity and Mortality Weekly Report2001;50:434–439.
2.
HolmesSA. AIDS deaths in U.S. drop by nearly half as infections go on. New York Times, October 8, 1998:A1.
3.
MartinJASmithBLMathewsTJVenturaSJ. Births and deaths: Preliminary data for 1998. National Vital Statistics Reports1999;47(25):1–8.
4.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Midyear Edition; 1998:10(1).
5.
U.S. Census Bureau. Resident population estimates of the United States by sex, race, and Hispanic origin: April 1, 1990 to November 1, 1999. Washington, DC: Population Estimates Program, Population Division, U.S. Census Bureau, 1999.
6.
Centers for Disease Control and Prevention. HIV/AIDS—United States, 1981–2001. Morbidity and Mortality Weekly Report2001;50:430–434.
7.
CollierACCoombsRWSchoenfeldDABassettRLTimponeJBaruchAJonesMFaceyKWhitacreCMcAuliffeVJFriedmanHMMeriganTCReichmanRCHooperCCoreyL. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. New England Journal of Medicine1996;334:1011–1018.
8.
DannerSACarrALeonardJMLehmanLMGudiolFGonzalesJRaventosARubioRBouzaEPintadoVAguadoAGde LomasJ GarciaDelgadoRBorleffsJCCHsuAValdesJMBoucherCABCooperDA. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. New England Journal of Medicine1995;333:1528–1534.
9.
GulickRMMellorsJWHavlirDEronJJGonzalezCMcMahonDRichamanDDValentineFTJonasLMeibohmAEminiEAChodakewitzJA. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine1997;337:734–739.
10.
MarkowitzMConantMHurleyASchlugerRDuranMPeterkinJChapmanSPatickAHendricksAYuenGJHoskinsWClendeninnNHoDD. A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HI)-1 protease, to treat HIV infection. Journal of Infectious Diseases1998;177:1533–1540.
11.
MoyleGJYouleMHiggsCMonaghanJPrinceWChapmanSClendeninnNNelsonMR. Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: Results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus. Journal of Clinical Pharmacology1998;38:726–743.
12.
DeeksSGHechtFMSwansonMElbeikTLoftusRCohenPTGrantRM. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy. AIDS1999;13:F35–43.
13.
FatkenheuerGTheisenARockstrohJGrabowTWickeCBeckerKWielandUPfisterHReiserMHegenerPFranzenCSchwenkASalzbergerB. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS1997;11:F113–F116.
14.
LedergerberBEggerMOpravilMTelentiAHirschelBBattegayMVernazzaPSudrePFleppMFurrerHFrancioliPWeberR. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Lancet1999;353:863–868.
15.
RabkinJGFerrandoS. A “second life” agenda: Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. Archives of General Psychiatry1997;54:1049–1053.
16.
Gore-FeltonCButlerLDKoopmanC. HIV disease, violence, and post-traumatic stress. FOCUS: A Guide to AIDS Research and Counseling2001;16:5–6.
17.
SimoniJMNgMT. Trauma, coping, and depression among women with HIV/AIDS in New York City. AIDS Care2000;12:567–580.
18.
Carballo-DieguezADolezalC. Association between history of childhood sexual abuse and adult HIV-risk sexual behavior in Puerto Rican men who have sex with men. Child Abuse and Neglect1995;19:595–605.
19.
MillerMPaoneD. Social network characteristics as mediators in the relationship between sexual abuse and HIV risk. Social Science and Medicine1998;47:765–777.
20.
WinwoodGMDiClementeRJ. Child sexual abuse, HIV sexual risk, and gender relations of African-American women. American Journal of Preventive Medicine1998;13:380–384.
21.
BedimoALKissingerPBessingerR. History of sexual abuse among HIV-infected women. International Journal of STDs and AIDS1997;8:332–335.
22.
HeHMcCoyHVStevensSJStarkMJ. Violence and HIV sexual risk behaviors among female sex partners of male drug users. Women Health1998;27:161–175.
23.
PerrySWFishmanBJacobsbergLFrancesA. Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Archives of General Psychiatry1992;49:396–401.
24.
EvansDLLesermanJPerkinsDOSternRAMurphyCZhengBGettesDLongmateJASilvaSGvan der HorstCMHallCDFoldsJDGoldenRNPetittoJM. Severe life stress as a predictor of early disease progression in HIV infection. American Journal of Psychiatry1997;154:630–634.
25.
ColeSWKemenyMETaylorSEVisscherBRFaheyJL. Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosomatic Medicine1996;58:219–231.
26.
KimerlingRArmisteadLForehandR. Victimization experiences and HIV infection in women: Associations with serostatus, psychological symptoms, and health status. Journal of Traumatic Stress1999;12:41–58.
27.
McEwenBS. Protective and damaging effects of stress mediators. New England Journal of Medicine1998;338:171–179.
28.
RosmondRDallmanMBjorntorpP. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. Journal of Clinical Endocrinological Metabolism1998;83:1842–1845.
29.
EnwonwuCOMeeksVISawirisPG. Elevated cortisol levels in whole saliva in HIV infected individuals. European Journal of Oral Sciences1996;104:322–324.
30.
GlaserRKiecolt-GlaserJKMaruchaPTMacCallumRCLaskowkiBFMalarkeyWB. Stress-related changes in proinflammatory cytokine production in wounds. Archives of General Psychiatry1999;56:450–456.
31.
ColeSWKemenyME. Psychobiology of HIV infection. Critical Reviews in Neurobiology1997;11:289–321.
32.
FriedmanMJSchnurrPP. The relationship between trauma, post-traumatic stress disorder, and physical health. In: FriedmanMJCharneyDSDeutchAY, eds., Neurobiological and clinical consequences of stress: From normal adaptation to PTSD. Philadelphia: Lippincott-Raven Publishers; 1995:507–524.
33.
KoopmanCClassenCCardeñaESpiegelD. When disaster strikes, acute stress disorder may follow. Journal of Traumatic Stress1995;8:29–46.
34.
BryantRHarveyAGGuthrieRMMouldsML. A prospective study of psychophysiological arousal, acute stress disorder, and posttraumatic stress disorder. Journal of Abnormal Psychology2000;109:341–344.
35.
CardenaESpiegelD. Dissociative reactions to the Bay Area Earthquake. American Journal of Psychiatry1993;150:474–478.
36.
ClassenCKoopmanCHalesRSpiegelD. Acute stress reactions as a predictor of post-traumatic stress symptoms. American Journal of Psychiatry1998;155:620–624.
37.
FreinkelAKoopmanCSpiegelD. Dissociative symptoms in media execution witnesses. American Journal of Psychiatry1994;151:1335–1339.
38.
KoopmanCClassenCSpiegelD. Dissociative responses in the immediate aftermath of the Oakland/Berkeley firestorm. Journal of Traumatic Stress1996;9:521–540.
39.
MarmarCRWeissDSSchlengerWEFairbankJAJordanBKKulkaRAHoughRL. Peritraumatic dissociation and posttraumatic stress in male Vietnam theater veterans. American Journal of Psychiatry1994;151:902–907.
40.
WaeldeLCKoopmanCRierdanJSpiegelD. Symptoms of acute stress disorder and posttraumatic stress disorder following exposure to disastrous flooding. Journal of Trauma and Dissociation2001;2:37–52.
41.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.Washington, DC: American Psychiatric Association; 1994.
42.
KoopmanCGore-FeltonCClassenCKimPSpiegelD. Acute stress reactions to everyday stressful life events among sexual abuse survivors with PTSD. Journal of Child Sexual Abuse2001;10:83–99.
43.
CharneyDSDeutchAYSouthwickSMKrystalJH. Neural circuits and mechanisms of post-traumatic stress disorder. In: FriedmanMJCharneyDSDeutchAY, eds., Neurobiological and clinical consequences of stress: From normal adaptation to PTSD. Philadelphia: Lippincott-Raven Publishers; 1995:271–287.
44.
KoopmanCGore-FeltonCSpiegelD. Acute stress disorder symptoms among sex abuse survivors seeking treatment. Journal of Child Sexual Abuse1997;6:65–85.
45.
KoopmanCDrescherKBowlesSGusmanFBlakeDDondershineHChangVButlerLSpiegelD. Acute dissociative symptoms in veterans with PTSD. Journal of Trauma and Dissociation2001;2:91–111.
46.
WeathersFWHuskaJAKeaneTM. The PTSD Checklist - Civilian Version (PCL-C). The National Center for PTSD, Boston, MA: Boston Veterans Affairs Medical Center; 1991.
47.
BlanchardEBJones-AlexanderJBuckleyTCFornerisCA. Psychometric properties of the PTSD Checklist (PCL). Behaviour Research and Therapy1996;34:669–73.
48.
CardeñaEClassenCKoopmanCSpiegelD. Review of the Stanford Acute Stress Reaction Questionnaire (SASRQ). In: StammBH, ed., Measurement of stress, trauma, and adaptation. Lutherville, MD: Sidran Press; 1996:293–297.
49.
CardenaEKoopmanCClassenCWaeldeLCSpiegelD. Psychometric properties of the Stanford Acute Stress Reaction Questionnaire (SASRQ): A valid and reliable measure of acute stress. Journal of Traumatic Stress2000;13:719–734.
50.
ClassenCDiamondSSolomonAFobairPSpiraJSpiegelD. Brief supportive-expressive group therapy for women with primary breast cancer: A treatment manual. Psychosocial Treatment Laboratory, breast cancer intervention project, Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, Stanford, California 94305; 1993.
51.
DiamondSGore-FeltonCGaleAGClassenCSpiegelD. Supportive-expressive group therapy for persons with HIV infection: A treatment manual. Psychosocial Treatment Laboratory, breast cancer intervention project, Stanford, CA: Department of Psychiatry and Behavioral Sciences, Stanford University; 1994.
52.
Gore-FeltonCSpiegelD. Enhancing women's lives: The role of support groups among breast cancer patients. Journal for Specialists in Group Work1999;24:274–287.
53.
SpiegelDYalomI. A support group for dying patients. International Journal of Group Psychotherapy1978;28:233–245.
54.
SpiegelDBloomJRYalomID. Group support for patients with metastatic cancer. A randomized prospective outcome study. Archives of General Psychiatry1981;38:527–533.
55.
SpiegelD. Psychosocial intervention in cancer. Journal of the National Cancer Institute1993;85:1198–1205.
56.
ClassenCButlerLDKoopmanCMillerEDiMiceliSGiese-DavisJFobairPCarlsonRWSpiegelD. Supportive-expressive group therapy reduces distress in metastatic breast cancer patients: A randomized clinical intervention trial. Archives of General Psychiatry2001;58:494–500.
57.
YalomIDGreavesC. Group therapy with the terminally ill. American Journal of Psychiatry1977;134:396–400.
58.
RabkinJGWilliamsJBNeugebauerRRemienRHGoetzR. Maintenance of hope in HIV-spectrum homosexual men. American Journal of Psychiatry1990;147(10): 1322–1326.
59.
RabkinJGGoetzRRRemienRHWilliamsJBTodakGGormanJM. Stability of mood despite HIV illness progression in a group of homosexual men. American Journal of Psychiatry1997;154(2):231–238.
60.
NamirSWolcottDLFawzyFI. Coping with AIDS: Psychological and health implications. Journal of Applied Social Psychology1987;17:309–328.
61.
WolfTMBalsonPMMorseEVSimonPMGaumerRHDrallePWWilliamsMH. Relationship of coping style to affective state and perceived social support in asymptomatic and symptomatic HIV-infected persons: Implications for clinical management. Journal of Clinical Psychiatry1991;52:171–173.
62.
FriedlandJRenwickRMcCollM. Coping and social support as determinants of quality of life in HIV/AIDS. AIDS Care1996;8:15–31.
63.
GoodkinKBlaneyNTFeasterDFletcherMABaumMKMantero-AtienzaEKlimasNGMillonCSzapocznikJEisdorferC. Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men. Journal of Psychosomatic Research1992;36:635–650.
64.
GoodkinKFuchsIFeasterDLeekaJRishelDD. Life stressors and coping style are associated with immune measures in HIV-1 infection. A preliminary report. International Journal of Psychiatry in Medicine1992;22:155–172.
65.
AntoniMHCruessDGCruessSLutgendorfSKumarMIronsonGKlimasNFletcherMASchneidermanN. Cognitive-behavioral stress management intervention effects on anxiety, 24-hour urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. Journal of Consulting & Clinical Psychology2000;68(1):31–45.
66.
LutgendorfSKAntoniMHIronsonGKlimasNKumarMStarrKMcCabePClevenKFletcherMASchneidermanN. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-Type 2 antibody titers in symptomatic HIV-seropositive gay men. Journal of Consulting & Clinical Psychology1997;65(1):31–43.
67.
LutgendorfSKAntoniMHIronsonGStarrKCostelloNZuckermanMKlimasNFletcherMASchneidermanN. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men. Psychosomatic Medicine1998;60(2):204–214.
